STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 62 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $5,955,000 | +16.7% | 556,567 | +18.2% | 0.00% | 0.0% |
Q3 2016 | $5,102,000 | +72.1% | 471,055 | +7.5% | 0.00% | 0.0% |
Q2 2016 | $2,965,000 | +56.6% | 438,016 | +7.8% | 0.00% | – |
Q1 2016 | $1,893,000 | -25.9% | 406,268 | +0.4% | 0.00% | -100.0% |
Q4 2015 | $2,553,000 | -26.2% | 404,544 | +3.2% | 0.00% | 0.0% |
Q3 2015 | $3,460,000 | -25.9% | 391,825 | -1.2% | 0.00% | 0.0% |
Q2 2015 | $4,667,000 | -21.8% | 396,517 | -3.8% | 0.00% | 0.0% |
Q1 2015 | $5,965,000 | +6.2% | 412,243 | +25.2% | 0.00% | 0.0% |
Q4 2014 | $5,617,000 | +64.7% | 329,254 | +20.3% | 0.00% | 0.0% |
Q3 2014 | $3,410,000 | -18.5% | 273,698 | -4.0% | 0.00% | 0.0% |
Q2 2014 | $4,183,000 | -24.4% | 285,109 | +4.9% | 0.00% | -50.0% |
Q1 2014 | $5,532,000 | +7.4% | 271,721 | +3.4% | 0.00% | 0.0% |
Q4 2013 | $5,149,000 | -56.2% | 262,713 | +1.2% | 0.00% | -50.0% |
Q3 2013 | $11,760,000 | +115.3% | 259,622 | +13.3% | 0.00% | +100.0% |
Q2 2013 | $5,462,000 | – | 229,093 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 475,200 | $6,877,000 | 3.03% |
Avoro Capital Advisors LLC | 475,000 | $6,873,000 | 2.64% |
VHCP Management, LLC | 451,400 | $6,532,000 | 1.50% |
Sio Capital Management, LLC | 140,000 | $2,026,000 | 1.15% |
Opus Point Partners Management, LLC | 75,000 | $1,085,000 | 0.91% |
Eventide Asset Management | 620,200 | $8,974,000 | 0.68% |
Telemetry Investments, L.L.C. | 55,000 | $796,000 | 0.44% |
Healthcare Value Capital, LLC | 25,000 | $362,000 | 0.40% |
TFS CAPITAL LLC | 259,916 | $3,761,000 | 0.37% |
FARALLON CAPITAL MANAGEMENT LLC | 672,562 | $9,732,000 | 0.14% |